Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Gitlin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cardiovascular Research|October 25, 2008
Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in miceJonathan M Gitlin, Charles D Loftin
Journal of Cardiovascular Pharmacology|September 13, 2012
Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotypeKamalika Mukherjee, Jonathan M Gitlin, Charles D Loftin
Cardiovascular Research|December 2, 2006
Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in miceJonathan M Gitlin, Darshini B Trivedi, Robert Langenbach, et al.
British Journal of Pharmacology|June 6, 2003
Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric arteryHammit Mistry, Jonathan M Gitlin, Jane A Mitchell, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 2006
Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in miceVictoria L King, Darshini B Trivedi, Jonathan M Gitlin, et al.
The American Journal of Pathology|December 6, 2008
Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in miceJonathan M Gitlin, Jonathon W Homeister, Joshua Bulgrien, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 3, 2010
Carrier testing for spinal muscular atrophyJonathan M Gitlin, Kenneth Fischbeck, Thomas O Crawford, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cardiovascular Research|October 25, 2008
Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in miceJonathan M Gitlin, Charles D Loftin
Journal of Cardiovascular Pharmacology|September 13, 2012
Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotypeKamalika Mukherjee, Jonathan M Gitlin, Charles D Loftin
Cardiovascular Research|December 2, 2006
Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in miceJonathan M Gitlin, Darshini B Trivedi, Robert Langenbach, et al.
British Journal of Pharmacology|June 6, 2003
Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric arteryHammit Mistry, Jonathan M Gitlin, Jane A Mitchell, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 2006
Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in miceVictoria L King, Darshini B Trivedi, Jonathan M Gitlin, et al.
The American Journal of Pathology|December 6, 2008
Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in miceJonathan M Gitlin, Jonathon W Homeister, Joshua Bulgrien, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 3, 2010
Carrier testing for spinal muscular atrophyJonathan M Gitlin, Kenneth Fischbeck, Thomas O Crawford, et al.
Pageof 1